Why should you participate:
MBFD test specializes in the research and development of professional and high-quality services in the field of clinical genetic testing.
This test analyses circulating cell-free DNA extracted from a maternal blood sample. Indicated for use in pregnant women with increased risk for chromosomal aneuploidy.
The test is capable of genome-wide aneuploidy detection over the whole fetal genome and offers an interpretation of the results for Trisomy 13 Trisomy 18 and Trisomy 21. This test confers an accuracy of up to 99% on the detection of fetal chromosome aneuploidy.
National Head, Molecular Diagnostics, R& D
Reference Lab, National Reference Laboratory Dr Lal PathLabs Ltd
I accept all
terms and conditions